BPH is an enlarged prostate gland. This is a common diagnosis as men age. For most, the enlargement doesn’t usually cause problems until later in their life.
According to the National Institute of Diabetes and Digestive and Kidney Diseases:
The UroLift® System is a revolutionary treatment for benign prostatic hyperplasia (BPH). More than 37 million men in the United States are affected by BPH. Clinical data has shown that the UroLift® System treatment is safe and effective. This minimally invasive approach to treating BPH is a great option for patients looking for an alternative to medication.
It’s a nonsurgical procedure that places tiny implants to lift and hold the enlarged prostate tissue out of the way, so it no longer blocks the urethra, resulting in improved urination. There is no cutting, heating or removal of prostate tissue.
UroLift® is a simple surgery with minimal downtime. UroLift® is generally performed in the office under local or general anesthesia. Typically, patients can return home the same day and will see an improvement to their urinary tract symptoms as early as two weeks post procedure. In some cases, patients may return home the same day, with a catheter that will be removed in a couple of days. The fast recovery means you can get back to your normal life and activities.